Discover investment opportunities in Israel Stocks Listed In Us using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Israel Stocks Listed In Us using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Israel Stocks Listed In Us using our Smart AI Filter.
7 stocks found for "Israel Stocks Listed In Us"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.80 | ±40.9% | 14.0 | 0.38% | |||
0.45 | ±35.3% | 20.3 | 3.16% | |||
0.72 | ±41.2% | 19.9 | 0.00% | |||
1.03 | ±49.2% | 6.1 | 2.00% | |||
0.84 | ±36.4% | 13.2 | 0.00% | |||
0.65 | ±71.0% | -1.1 | 0.00% | |||
1.11 | ±52.3% | 37.8 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What factors contribute to the appeal of Check Point Software Technologies (CHKP) for technology investors?
A: Check Point Software Technologies (CHKP) is attractive due to its strong presence in cybersecurity, a critical growth sector. The company's consistent R&D investments and innovative product offerings enhance its competitive advantage. Its global customer base and established reputation in network security solutions may also provide stability.
Q: How does Teva Pharmaceuticals (TEVA) fit into a value-oriented investment strategy?
A: Teva Pharmaceuticals (TEVA) might appeal to value investors as it trades at a lower valuation due to recent challenges. Its efforts in restructuring and expanding generics could indicate potential recovery. However, investors should assess risks tied to litigation and fluctuating generic drug prices.
Q: In what ways do fluctuations in the U.S. dollar impact SodaStream (SODA) sales?
A: As SodaStream (SODA) operates globally, U.S. dollar fluctuations can affect its revenue when converted from foreign currencies. A strong dollar may reduce reported earnings, whereas a weaker dollar could enhance them. Currency hedging strategies may mitigate some impacts but risks remain.
Q: What roles do geopolitical risks play in the performance of Israel Chemicals (ICL)?
A: Israel Chemicals (ICL), with operations tied to specific regions, may face geopolitical risks affecting supply chains or market access. Political tensions can disrupt production or alter trade relationships, impacting financial performance. Monitoring geopolitical developments is crucial for investors.
Q: Does Nova Measuring Instruments (NVMI) show potential for growth investors seeking semiconductor exposure?
A: Nova Measuring Instruments (NVMI) may attract growth investors due to its advanced metrology solutions critical to semiconductor manufacturing. The global demand for semiconductors and the company's innovative product pipeline might suggest long-term expansion opportunities.
Q: How might Playtika Holding Corp (PLTK)'s focus on mobile gaming impact its revenue growth?
A: Playtika Holding Corp (PLTK) depends on mobile gaming trends, which are growing rapidly worldwide. Its diverse game portfolio and user engagement strategies might drive revenue, yet competitive pressures and evolving consumer preferences in technology necessitate careful market analysis.
InterCure Ltd. INCR has shown resilience in its H1 2024 performance despite facing significant challenges, according to equity research by Pablo Zuanic of Zuanic & Associates.
Read more